Advanced or metastatic breast cancer and other advanced or metastatic solid tumors research hub

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

This study is looking at a new medicine called inavolisib. It's for people with advanced breast cancer or other solid tumours. Researchers want to see if it's safe, how the body handles it, and if it works alone or with other treatments for breast cancer.